Wealthcare Advisory Partners’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $893K | Sell |
8,632
-1,146
| -12% | -$102K | 0.02% | 544 |
|
|
2026
Q1 | $702K | Sell |
9,778
-208
| -2% | -$16K | 0.01% | 604 |
|
|
2025
Q4 | $792K | Sell |
9,986
-385
| -4% | -$30.4K | 0.02% | 573 |
|
|
2025
Q3 | $782K | Buy |
10,371
+489
| +5% | +$33.5K | 0.02% | 568 |
|
|
2025
Q2 | $682K | Sell |
9,882
-102
| -1% | -$6.69K | 0.02% | 568 |
|
|
2025
Q1 | $676K | Sell |
9,984
-36
| -0.4% | -$2.15K | 0.02% | 518 |
|
|
2024
Q4 | $450K | Sell |
10,020
-605
| -6% | -$33.9K | 0.01% | 598 |
|
|
2024
Q3 | $668K | Sell |
10,625
-670
| -6% | -$39.1K | 0.02% | 504 |
|
|
2024
Q2 | $667K | Sell |
11,295
-759
| -6% | -$47.5K | 0.02% | 475 |
|
|
2024
Q1 | $961K | Sell |
12,054
-282
| -2% | -$21.5K | 0.03% | 379 |
|
|
2023
Q4 | $974K | Buy |
12,336
+45
| +0.4% | +$3.2K | 0.04% | 318 |
|
|
2023
Q3 | $858K | Sell |
12,291
-782
| -6% | -$55.4K | 0.04% | 308 |
|
|
2023
Q2 | $904K | Sell |
13,073
-101
| -0.8% | -$7.19K | 0.04% | 310 |
|
|
2023
Q1 | $979K | Buy |
13,174
+460
| +4% | +$38.6K | 0.04% | 293 |
|
|
2022
Q4 | $1.18M | Buy |
12,714
+5,170
| +69% | +$499K | 0.06% | 249 |
|
|
2022
Q3 | $719K | Buy |
7,544
+307
| +4% | +$30.4K | 0.04% | 283 |
|
|
2022
Q2 | $671K | Sell |
7,237
-37
| -0.5% | -$3.61K | 0.04% | 266 |
|
|
2022
Q1 | $736K | Sell |
7,274
-1,001
| -12% | -$105K | 0.04% | 244 |
|
|
2021
Q4 | $854K | Buy |
8,275
+829
| +11% | +$76.6K | 0.05% | 222 |
|
|
2021
Q3 | $632K | Buy |
7,446
+250
| +3% | +$20.9K | 0.04% | 276 |
|
|
2021
Q2 | $600K | Sell |
7,196
-72
| -1% | -$5.9K | 0.04% | 282 |
|
|
2021
Q1 | $547K | Buy |
7,268
+2,019
| +38% | +$147K | 0.04% | 272 |
|
|
2020
Q4 | $359K | Buy |
5,249
+141
| +3% | +$9.17K | 0.03% | 294 |
|
|
2020
Q3 | $298K | Buy |
5,108
+33
| +0.7% | +$2.05K | 0.03% | 273 |
|
|
2020
Q2 | $330K | Buy |
5,075
+1,360
| +37% | +$85.6K | 0.04% | 226 |
|
|
2020
Q1 | $220K | Buy |
3,715
+174
| +5% | +$11.6K | 0.03% | 250 |
|
|
2019
Q4 | $263K | Buy |
3,541
+317
| +10% | +$22.3K | 0.03% | 257 |
|
|
2019
Q3 | $203K | Sell |
3,224
-66
| -2% | -$3.91K | 0.03% | 272 |
|
|
2019
Q2 | $179K | Buy |
3,290
+390
| +13% | +$21K | 0.03% | 286 |
|
|
2019
Q1 | $156K | Buy |
2,900
+1,059
| +58% | +$65.4K | 0.03% | 271 |
|
|
2018
Q4 | $121K | Buy |
1,841
+158
| +9% | +$11.8K | 0.02% | 277 |
|
|
2018
Q3 | $132K | Sell |
1,683
-1,007
| -37% | -$72K | 0.02% | 286 |
|
|
2018
Q2 | $173K | Buy |
2,690
+1,382
| +106% | +$91.1K | 0.03% | 235 |
|
|
2018
Q1 | $81K | Sell |
1,308
-55
| -4% | -$3.95K | 0.02% | 316 |
|
|
2017
Q4 | $99K | Buy |
1,363
+72
| +6% | +$5.24K | 0.03% | 255 |
|
|
2017
Q3 | $105K | Buy |
1,291
+991
| +330% | +$78.4K | 0.03% | 205 |
|
|
2017
Q2 | $24K | Hold |
300
| – | – | 0.01% | 61 |
|
|
2017
Q1 | $24K | Hold |
300
| – | – | 0.01% | 57 |
|
|
2016
Q4 | $24K | Buy |
+300
| New | +$24.3K | 0.01% | 61 |
|
Other funds holding CVS
LMFP
CF
HCM
FWIA
CGH
Wealthcare Advisory Partners's CVS Position: Q2 2026 in Review
Wealthcare Advisory Partners reduced its CVS Health (CVS) stake by 12% in Q2 2026, selling an estimated $102K and leaving 8,632 shares worth $893K. The position accounts for 0.02% of the portfolio, ranked #544.
Wealthcare Advisory Partners first reported a position in CVS in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.18M in Q4 2022. 504 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Wealthcare Advisory Partners held 8,632 shares of CVS Health worth $893K as of Q2 2026.
- Wealthcare Advisory Partners sold 1,146 CVS Health shares in Q2 2026, an estimated $102K.
- CVS Health made up 0.02% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #544 holding.
- Wealthcare Advisory Partners first reported a position in CVS Health in Q4 2016 and has held it in 39 quarters since.
- Wealthcare Advisory Partners's CVS Health position peaked at $1.18M in Q4 2022.
- 504 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.